Practical management of mild-to-moderate ulcerative colitis: an international expert consensus

被引:0
|
作者
D'Amico, Ferdinando [1 ]
Magro, Fernando [2 ]
Dignass, Axel [3 ]
Al Awadhi, Sameer [4 ]
Gutierrez Casbas, Ana [5 ,6 ]
Queiroz, Natalia Sousa Freitas [7 ]
Rydzewska, Grazyna [8 ]
Duk Ye, Byong [9 ]
Ran, Zhihua [10 ]
Hart, Ailsa [11 ]
Jairath, Vipul [12 ,13 ]
Fiorino, Gionata [14 ]
Peyrin-Biroulet, Laurent [15 ,16 ,17 ,18 ,19 ,20 ]
Danese, Silvio [1 ,21 ]
机构
[1] IRCCS San Raffaele Hosp, Gastroenterol & Endoscopy, Via Olgettina 60, Milan, Italy
[2] Univ Porto, Fac Med, CINTESIS RISE, Porto, Portugal
[3] Goethe Univ, Agaples Markus Hosp, Dept Med 1, Frankfurt, Germany
[4] Dubai Hlth, Rashid Hosp, Digest Dis Unit, Dubai, U Arab Emirates
[5] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol, Madrid, Spain
[6] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Dept Gastroenterol, Alicante, Spain
[7] Santa Cruz Hosp, Gastroenterol Unit, Curitiba, Brazil
[8] Natl Med Inst Minist Interior & Adm, Dept Gastroenterol & Internal Med, Warsaw, Poland
[9] Univ Ulsan, Inflammatory Bowel Dis Ctr, AsanMed Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[10] Shanghai Univ Med & Hlth Sci, Zhou Pu Hosp, Dept Gastroenterol, Shanghai, Peoples R China
[11] St Marks Hosp, Inflammatory Bowel Dis Unit, London, England
[12] Western Univ, Dept Gastroenterol, Schulich Sch Med & Dent, London, ON, Canada
[13] Western Univ, Schulich Sch Med & Dent, Dept Med, London, ON, Canada
[14] San Camillo Forlanini Hosp, Dept Gastroenterol & Digest Endoscopy, IBD Unit, Rome, Italy
[15] Nancy Univ Hosp, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[16] Univ Lorraine, Dept Gastroenterol, Inserm, NGERE, Nancy, France
[17] Nancy Univ Hosp, INFINY Inst, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[18] Nancy Univ Hosp, FHU CURE, Dept Gastroenterol, Nancy, France
[19] Grp Hosp Prive Ambroise Pare Hartmann, Paris IBD Ctr, Dept Gastroenterol, Neuilly Sur Seine, France
[20] McGill Univ, Hlth Ctr, Div Gastroenterol & Hepatol, Dept Gastroenterol, Montreal, PQ, Canada
[21] Univ Vita Salute San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
关键词
Ulcerative colitis; inflammatory bowel disease; mesalamine; 5-ASA; budesonide MMX; INFLAMMATORY-BOWEL-DISEASE; 5-AMINOSALICYLIC ACID THERAPY; FECAL CALPROTECTIN; CLINICAL-TRIAL; ORAL MESALAZINE; MAINTENANCE TREATMENT; CROHNS-DISEASE; FOLLOW-UP; MESALAMINE; REMISSION;
D O I
10.1080/17474124.2024.2397650
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionAlthough there are well-defined guidelines for the management of mild-to-moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted an international expert consensus to standardize the management of patients with mild-to-moderate UC and provide practical guidance to clinicians.Areas coveredBased on Delphi methodology, 15 statements were approved after two rounds of voting, addressing several aspects of disease management from sequencing to treatment duration, from monitoring to optimization techniques and safety profile.Expert opinionGrowing knowledge of mild-to-moderate UC has led to the development of new ambitious outcomes such as histological remission and disease clearance. Furthermore, noninvasive tools for patient monitoring such as fecal calprotectin and intestinal ultrasound are now available. Their implementation in clinical practice will allow clinicians to tightly monitor disease activity and promptly adapt treatment, avoiding complications and disease progression and targeting better disease control.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [41] Symptomatic resolution is an inadequate predictor of complete colonic mucosal healing in mild-to-moderate ulcerative colitis
    Kornbluth, Asher
    Kamm, Michael A.
    Lichtenstein, Gary R.
    Sandborn, William J.
    Barrett, Karen
    Lees, Kirstin H.
    Joseph, Raymond E.
    GASTROENTEROLOGY, 2007, 132 (04) : A506 - A506
  • [42] Optimizing treatment of mild to moderate ulcerative colitis: CU-forum Delphi consensus
    Cuffi, Miquel Sans
    Arias, Federico Arguelles
    Piudo, Ana Echarri
    Vicens, Daniel Ginard
    Casbas, Ana Gutierrez
    Marin-Jimenez, Ignacio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (10): : 784 - 794
  • [43] Paracetamol and ibuprofen combination for the management of acute mild-to-moderate pain in children: expert consensus using the Nominal Group Technique (NGT)
    Parri, Niccolo
    Silvagni, Davide
    Chiarugi, Alberto
    Cortis, Elisabetta
    D'Avino, Antonio
    Lanari, Marcello
    Marchisio, Paola Giovanna
    Vezzoli, Cesare
    Zampogna, Stefania
    Staiano, Annamaria
    ITALIAN JOURNAL OF PEDIATRICS, 2023, 49 (01)
  • [44] Paracetamol and ibuprofen combination for the management of acute mild-to-moderate pain in children: expert consensus using the Nominal Group Technique (NGT)
    Niccolò Parri
    Davide Silvagni
    Alberto Chiarugi
    Elisabetta Cortis
    Antonio D’Avino
    Marcello Lanari
    Paola Giovanna Marchisio
    Cesare Vezzoli
    Stefania Zampogna
    Annamaria Staiano
    Italian Journal of Pediatrics, 49
  • [45] Combined Diosmectite and Mesalazine Treatment for Mild-to-Moderate Ulcerative Colitis: A Randomized, Placebo-Controlled Study
    Jiang, Xue-Liang
    Wang, Hua-Hong
    Cui, Hui-Fei
    MEDICAL SCIENCE MONITOR, 2015, 21 : 163 - 170
  • [46] Segmental Endoscopic Evaluation of Combined Oral and Topical Mesalazine (Pentasa®) in Patients With Mild-to-Moderate Ulcerative Colitis
    Suzuki, Yasuo
    Inou, Soetsu
    Uchiyama, Kan
    Kato, Masahisa
    Matsuo, Keigo
    Nakagawa, Tomoo
    Kato, Kazuki
    Kishikawa, Hiroshi
    Kimura, Norio
    GASTROENTEROLOGY, 2012, 142 (05) : S655 - S655
  • [47] Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial
    Lang, Alon
    Salomon, Nir
    Wu, Justin C. Y.
    Kopylov, Uri
    Lahat, Adi
    Har-Noy, Ofir
    Ching, Jessica Y. L.
    Cheong, Pui Kuan
    Avidan, Benjamin
    Gamus, Dorit
    Kaimakliotis, Ioannis
    Eliakim, Rami
    Ng, Siew C.
    Ben-Horin, Shomron
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (08) : 1444 - +
  • [48] A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS
    Danese, Silvio
    Hart, Ailsa
    Dignass, Axel
    Fiorino, Gionata
    Louis, Edouard
    D'Haens, Geert R.
    Dotan, Iris
    Rogler, Gerhard
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2019, 156 (06) : S1129 - S1129
  • [49] MMX mesalazine is well tolerated during 12 months' maintenance treatment of mild-to-moderate ulcerative colitis
    Kamm, M. A.
    Lichtenstein, G. R.
    Sandborn, W. J.
    Barrett, K.
    Joseph, R. E.
    GUT, 2007, 56 : A113 - A113
  • [50] MMX mesalamine for the treatment of active mild-to-moderate ulcerative colitis: An evidence-based medicine analysis
    Sandborn, William J.
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S431 - S432